Evidence map›Paper›PMID 35832630›Full record

ArticleComputational and structural biotechnology journal2022

Engineering and screening of novel β-1,3-xylanases with desired hydrolysate type by optimized ancestor sequence reconstruction and data mining.

Bo Zeng, ShuYan Zhao, Rui Zhou, YanHong Zhou, WenHui Jin, ZhiWei Yi, GuangYa Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bo ZengDepartment of Bioengineering and Biotechnology, Huaqiao University, Xiamen, Fujian Province 361021, China.
ShuYan ZhaoDepartment of Bioengineering and Biotechnology, Huaqiao University, Xiamen, Fujian Province 361021, China.
Rui ZhouDepartment of Bioengineering and Biotechnology, Huaqiao University, Xiamen, Fujian Province 361021, China.
YanHong ZhouDepartment of Bioengineering and Biotechnology, Huaqiao University, Xiamen, Fujian Province 361021, China.
WenHui JinTechnology Innovation Center for Exploitation of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen, Fujian Province 361005, China.
ZhiWei YiTechnology Innovation Center for Exploitation of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen, Fujian Province 361005, China.
GuangYa ZhangDepartment of Bioengineering and Biotechnology, Huaqiao University, Xiamen, Fujian Province 361021, China.
Huaqiao University · CNMinistry of Natural Resources · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineering of hydrolases to shift their hydrolysate types has not been attempted so far, though computer-assisted enzyme design has been successful. A novel integrative strategy for engineering and screening the β-1,3-xylanase with desired hydrolysate types was proposed, with the purpose to solve problems that the separation and preparation of β-1,3-

Indexed as

Data miningHydrolase engineering and screeningOptimized ancestor protein reconstructionβ-1,3-xylo-oligosaccharides production

Identifiers

PMID35832630
PMCPMC9251504
OpenAlexW4283593804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.